Website Update: Email Subscriptions Discontinued

Posted by
  Website Update: Email Subscriptions Discontinued I want to share an important update regarding email subscriptions and newsletters on Arácnido Taxonomy. Effective immediately, I have discontinued using Mailchimp for email newsletter subscriptions. Over the past several days, the subscription system and associated website functions have been subjected to persistent automated bot activity and attempted exploitation. In addition to generating unwanted subscription activity, these requests have contributed to periods of reduced website performance. To help protect the website, its content, and legitimate visitors, the Mailchimp subscription and registration functions have been removed. Following Arácnido Taxonomy via RSS For the foreseeable future, RSS will be the primary way to subscribe to and follow new posts and updates from Arácnido Taxonomy. RSS provides a simple, direct way to receive new content without submitting an email address or creating an account. Once the Arácnido Ta...

The Crude Venom of the Whitetail Lancehead, Bothrops leucurus, and Two of Its Enzymatic Components Are Selectively Cytotoxic for Glioma Cells In Vitro

Posted by

 


The Crude Venom of the Whitetail Lancehead, Bothrops leucurus, and Two of Its Enzymatic Components Are Selectively Cytotoxic for Glioma Cells In Vitro

ABSTRACT

Malignant glioma is the most common primary brain tumor, and glioblastoma multiforme (GBM) remains its most aggressive and incurable form. Snake venoms contain bioactive compounds with promising antitumoral properties against several cancer types. This study investigated the in vitro antitumor activity of Bothrops leucurus crude venom against rat and human glioma cells and identified two active venom enzymes. The crude venom showed concentration-dependent cytotoxicity, with EC50 values of 2.66 μg/mL for rat glioma cells and 3.60 μg/mL for human U251 glioma cells after 72 h. At 3.0 μg/mL, the venom induced necrotic death in glioma cells, whereas astrocytes remained viable. Two enzymes with anti-glioma activity were identified: the metalloprotease P-III leucurolysin-B and a basic phospholipase A2 (bPLA2). Both enzymes exhibited concentration-dependent cytotoxicity toward C6 and U251 glioma cells. Leucurolysin-B was more potent than bPLA2, presenting EC50 values of 1.44 and 2.25 μg/mL for C6 and U251 cells, respectively, while bPLA2 showed EC50 values of 30.00 and 39.81 μg/mL. Treatment with both enzymes reduced cellularity and induced morphological alterations in glioma cells without affecting healthy human astrocytes, indicating selective activity. Leucurolysin-B primarily induced apoptosis, whereas bPLA2 mainly caused necrosis. These findings demonstrate the antitumor potential of B. leucurus venom, particularly leucurolysin-B, as a promising candidate for glioma therapy development. Overall, the results suggest that venom-derived molecules may represent prototypes for developing therapies against malignant gliomas, combining efficacy with reduced toxicity toward normal glial cells. Further studies are required to clarify their mechanisms of action and evaluate their potential experimentally.

V. Rosário, O. H., Fucase, T. M., Spencer, P. J., Sciani, J. M., Clarêncio, J., Rádis-Baptista, G., Casais-e-Silva, L. L., & El-Bachá, R. S. The Crude Venom of the Whitetail Lancehead, Bothrops leucurus, and Two of Its Enzymatic Components Are Selectively Cytotoxic for Glioma Cells In Vitro. Journal of Applied Toxicology. https://doi.org/10.1002/jat.70409